nach oben

Seminars in Immunopathology

Erschienen in:

01.03.2011 | Review

Regulatory T cells in lung transplantation—an emerging concept

verfasst von: David C. Neujahr, Christian P. Larsen

Erschienen in: Seminars in Immunopathology | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

Lung transplantation represents an option for patients with a variety of end-stage lung diseases. While surgical advances have led to improvements in short-term survival, long-term survival is limited by chronic rejection termed bronchiolitis obliterans syndrome (BOS). A growing body of work is devoted to determining why some patients develop BOS. One avenue of interest that has emerged recently is the role that regulatory T cells (Tregs) may have in protection from BOS. In this review, we will discuss the evidence that Tregs are relevant to outcomes following transplant. We will discuss the relevant animal models, in vitro assays, and human observational studies that support a role for Tregs. We will also explore the interplay between injurious T cells such as Th17 cells and Tregs as well as the effect that additional cell types and chemokines have on the balance between inflammation and regulation. Finally, we will review emerging therapies which may harness the ability of Tregs to lessen the effects of BOS.

Christie JD, Edwards LB, Aurora P et al (2009) The Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Lung and Heart-Lung Transplantation Report-2009. J Heart Lung Transplant 28:1031–1049PubMedCrossRef

Zheng XX, Sanchez-Fueyo A, Domenig C, Strom TB (2003) The balance of deletion and regulation in allograft tolerance. Immunol Rev 196:75–84PubMedCrossRef

Lerut J, Sanchez-Fueyo A (2006) An appraisal of tolerance in liver transplantation. Am J Transplant 6:1774–1780PubMedCrossRef

Martinez-Llordella M, Puig-Pey I, Orlando G et al (2007) Multiparameter immune profiling of operational tolerance in liver transplantation. Am J Transplant 7:309–319PubMedCrossRef

Bennett CL, Christie J, Ramsdell F et al (2001) The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27:20–21PubMedCrossRef

Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057–1061PubMedCrossRef

Fontenot JD, Gavin MA, Rudensky AY (2003) Foxp3 programs the development and function of CD4+ CD25+ regulatory T cells. Nat Immunol 4:330–336PubMedCrossRef

von Boehmer H (2005) Mechanisms of suppression by suppressor T cells. Nat Immunol 6:338–344CrossRef

Carrier Y, Yuan J, Kuchroo VK, Weiner HL (2007) Th3 cells in peripheral tolerance. I. Induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGF-beta T cell-transgenic mice. J Immunol 178:179–185PubMed

10.

Kay AB (2001) Allergy and allergic diseases. First of two parts. N Engl J Med 344:30–37PubMedCrossRef

11.

Haldar P, Pavord ID, Shaw DE et al (2008) Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 178:218–224PubMedCrossRef

12.

Molet S, Hamid Q, Davoine F et al (2001) IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol 108:430–438PubMedCrossRef

13.

Wakashin H, Hirose K, Maezawa Y et al (2008) IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice. Am J Respir Crit Care Med 178:1023–1032PubMedCrossRef

14.

Hartl D, Koller B, Mehlhorn AT et al (2007) Quantitative and functional impairment of pulmonary CD4+ CD25hi regulatory T cells in pediatric asthma. J Allergy Clin Immunol 119:1258–1266PubMedCrossRef

15.

Kearley J, Barker JE, Robinson DS, Lloyd CM (2005) Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+ CD25+ regulatory T cells is interleukin 10 dependent. J Exp Med 202:1539–1547PubMedCrossRef

16.

Kearley J, Robinson DS, Lloyd CM (2008) CD4+ CD25+ regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling. J Allergy Clin Immunol 122:617.e6–624.e6CrossRef

17.

Ware LB, Matthay MA (2000) The acute respiratory distress syndrome. N Engl J Med 342:1334–1349PubMedCrossRef

18.

Rubenfeld GD, Caldwell E, Peabody E et al (2005) Incidence and outcomes of acute lung injury. N Engl J Med 353:1685–1693PubMedCrossRef

19.

D'Alessio FR, Tsushima K, Aggarwal NR et al (2009) CD4+ CD25+ Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury. J Clin Invest 119:2898–2913PubMedCrossRef

20.

Haque MA, Mizobuchi T, Yasufuku K et al (2002) Evidence for immune responses to a self-antigen in lung transplantation: role of type V collagen-specific T cells in the pathogenesis of lung allograft rejection. J Immunol 169:1542–1549PubMed

21.

Yasufuku K, Heidler KM, O'Donnell PW et al (2001) Oral tolerance induction by type V collagen downregulates lung allograft rejection. Am J Respir Cell Mol Biol 25:26–34PubMed

22.

Yasufuku K, Heidler KM, Woods KA et al (2002) Prevention of bronchiolitis obliterans in rat lung allografts by type V collagen-induced oral tolerance. Transplantation 73:500–505PubMedCrossRef

23.

Lauer-Fields JL, Sritharan T, Stack MS, Nagase H, Fields GB (2003) Selective hydrolysis of triple-helical substrates by matrix metalloproteinase-2 and -9. J Biol Chem 278:18140–18145PubMedCrossRef

24.

Beeh KM, Beier J, Kornmann O, Micke P, Buhl R (2001) Sputum levels of metalloproteinase-9 and tissue inhibitor of metalloproteinase-1, and their ratio correlate with airway obstruction in lung transplant recipients: relation to tumor necrosis factor-alpha and interleukin-10. J Heart Lung Transplant 20:1144–1151PubMedCrossRef

25.

Taghavi S, Krenn K, Jaksch P, Klepetko W, Aharinejad S (2005) Broncho-alveolar lavage matrix metalloproteases as a sensitive measure of bronchiolitis obliterans. Am J Transplant 5:1548–1552PubMedCrossRef

26.

Hubner RH, Meffert S, Mundt U et al (2005) Matrix metalloproteinase-9 in bronchiolitis obliterans syndrome after lung transplantation. Eur Respir J 25:494–501PubMedCrossRef

27.

Soccal PM, Gasche Y, Miniati DN et al (2004) Matrix metalloproteinase inhibition decreases ischemia-reperfusion injury after lung transplantation. Am J Transplant 4:41–50PubMedCrossRef

28.

Bharat A, Fields RC, Trulock EP, Patterson GA, Mohanakumar T (2006) Induction of IL-10 suppressors in lung transplant patients by CD4+ 25+ regulatory T cells through CTLA-4 signaling. J Immunol 177:5631–5638PubMed

29.

Stassen M, Fondel S, Bopp T et al (2004) Human CD25+ regulatory T cells: two subsets defined by the integrins alpha 4 beta 7 or alpha 4 beta 1 confer distinct suppressive properties upon CD4+ T helper cells. Eur J Immunol 34:1303–1311PubMedCrossRef

30.

Bharat A, Fields RC, Steward N, Trulock EP, Patterson GA, Mohanakumar T (2006) CD4+ 25+ regulatory T cells limit Th1-autoimmunity by inducing IL-10 producing T cells following human lung transplantation. Am J Transplant 6:1799–1808PubMedCrossRef

31.

Mizobuchi T, Yasufuku K, Zheng Y et al (2003) Differential expression of Smad7 transcripts identifies the CD4+ CD45RChigh regulatory T cells that mediate type V collagen-induced tolerance to lung allografts. J Immunol 171:1140–1147PubMed

32.

Jiang S, Lechler RI, He XS, Huang JF (2006) Regulatory T cells and transplantation tolerance. Hum Immunol 67:765–776PubMedCrossRef

33.

Yamada Y, Sekine Y, Yoshida S et al (2009) Type V collagen-induced oral tolerance plus low-dose cyclosporine prevents rejection of MHC class I and II incompatible lung allografts. J Immunol 183:237–245PubMedCrossRef

34.

Burlingham WJ, Love RB, Jankowska-Gan E et al (2007) IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. J Clin Invest 117:3498–3506PubMedCrossRef

35.

Valencia X, Stephens G, Goldbach-Mansky R, Wilson M, Shevach EM, Lipsky PE (2006) TNF downmodulates the function of human CD4+ CD25hi T-regulatory cells. Blood 108:253–261PubMedCrossRef

36.

O’Sullivan BJ, Thomas HE, Pai S et al (2006) IL-1 beta breaks tolerance through expansion of CD25+ effector T cells. J Immunol 176:7278–7287PubMed

37.

Bettelli E, Carrier Y, Gao W et al (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235–238PubMedCrossRef

38.

Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B (2006) TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24:179–189PubMedCrossRef

39.

Mangan PR, Harrington LE, O'Quinn DB et al (2006) Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441:231–234PubMedCrossRef

40.

Deknuydt F, Bioley G, Valmori D, Ayyoub M (2009) IL-1beta and IL-2 convert human Treg into T(H)17 cells. Clin Immunol 131:298–307PubMedCrossRef

41.

Osorio F, LeibundGut-Landmann S, Lochner M et al (2008) DC activated via dectin-1 convert Treg into IL-17 producers. Eur J Immunol 38:3274–3281PubMedCrossRef

42.

Koenen HJ, Smeets RL, Vink PM, van Rijssen E, Boots AM, Joosten I (2008) Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood 112:2340–2352PubMedCrossRef

43.

Jaffar Z, Ferrini ME, Girtsman TA, Roberts K (2009) Antigen-specific Treg regulate Th17-mediated lung neutrophilic inflammation, B-cell recruitment and polymeric IgA and IgM levels in the airways. Eur J Immunol 39:3307–3314PubMedCrossRef

44.

Studer SM, George MP, Zhu X et al (2008) CD28 down-regulation on CD4 T cells is a marker for graft dysfunction in lung transplant recipients. Am J Respir Crit Care Med 178:765–773PubMedCrossRef

45.

Tai X, Cowan M, Feigenbaum L, Singer A (2005) CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat Immunol 6:152–162PubMedCrossRef

46.

Meloni F, Vitulo P, Bianco AM et al (2004) Regulatory CD4+ CD25+ T cells in the peripheral blood of lung transplant recipients: correlation with transplant outcome. Transplantation 77:762–766PubMedCrossRef

47.

Zeiser R, Nguyen VH, Beilhack A et al (2006) Inhibition of CD4+ CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production. Blood 108:390–399PubMedCrossRef

48.

Botturi K, Lacoeuille Y, Thomas P, Boniface S, Reynaud-Gaubert M, Magnan A (2008) CTLA-4-mediated regulatory phenotype of T-cells in tolerant lung recipients. Eur Respir J 31:1167–1176PubMedCrossRef

49.

Hwu P, Du MX, Lapointe R, Do M, Taylor MW, Young HA (2000) Indoleamine 2, 3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J Immunol 164:3596–3599PubMed

50.

Meloni F, Giuliano S, Solari N et al (2009) Indoleamine 2, 3-dioxygenase in lung allograft tolerance. J Heart Lung Transplant 28:1185–1192PubMedCrossRef

51.

Gregson AL, Hoji A, Saggar R et al (2008) Bronchoalveolar immunologic profile of acute human lung transplant allograft rejection. Transplantation 85:1056–1059PubMedCrossRef

52.

Neujahr DC, Cardona AC, Ulukpo O et al (2009) Dynamics of human regulatory T cells in lung lavages of lung transplant recipients. Transplantation 88:521–527PubMedCrossRef

53.

Bestard O, Cruzado JM, Rama I et al (2008) Presence of FoxP3+ regulatory T Cells predicts outcome of subclinical rejection of renal allografts. J Am Soc Nephrol 19:2020–2026PubMedCrossRef

54.

Muthukumar T, Dadhania D, Ding R et al (2005) Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med 353:2342–2351PubMedCrossRef

55.

Gavin MA, Torgerson TR, Houston E et al (2006) Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci USA 103:6659–6664PubMedCrossRef

56.

Wang J, Ioan-Facsinay A, van der Voort EI, Huizinga TW, Toes RE (2007) Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur J Immunol 37:129–138PubMedCrossRef

57.

Janson PC, Winerdal ME, Marits P, Thorn M, Ohlsson R, Winqvist O (2008) FOXP3 promoter demethylation reveals the committed Treg population in humans. PLoS ONE 3(2):e1612PubMedCrossRef

58.

Mamessier E, Lorec AM, Thomas P, Badier M, Magnan A, Reynaud-Gaubert M (2007) T regulatory cells in stable posttransplant bronchiolitis obliterans syndrome. Transplantation 84:908–916PubMedCrossRef

59.

Belperio JA, Keane MP, Burdick MD et al (2003) Role of CXCL9/CXCR3 chemokine biology during pathogenesis of acute lung allograft rejection. J Immunol 171:4844–4852PubMed

60.

Yang ZZ, Novak AJ, Stenson MJ, Witzig TE, Ansell SM (2006) Intratumoral CD4+ CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma. Blood 107:3639–3646PubMedCrossRef

61.

Curiel TJ, Coukos G, Zou L et al (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10:942–949PubMedCrossRef

62.

Maeda A, Schwarz A, Kernebeck K et al (2005) Intravenous infusion of syngeneic apoptotic cells by photopheresis induces antigen-specific regulatory T cells. J Immunol 174:5968–5976PubMed

63.

Maeda A, Schwarz A, Bullinger A, Morita A, Peritt D, Schwarz T (2008) Experimental extracorporeal photopheresis inhibits the sensitization and effector phases of contact hypersensitivity via two mechanisms: generation of IL-10 and induction of regulatory T cells. J Immunol 181:5956–5962PubMed

64.

Bladon J, Taylor P (2002) Extracorporeal photopheresis reduces the number of mononuclear cells that produce pro-inflammatory cytokines, when tested ex-vivo. J Clin Apher 17:177–182PubMedCrossRef

65.

Rao V, Saunes M, Jorstad S, Moen T (2009) Cutaneous T cell lymphoma and graft-versus-host disease: a comparison of in vivo effects of extracorporeal photochemotherapy on Foxp3+ regulatory T cells. Clin Immunol 133:303–313PubMedCrossRef

66.

Schmitt S, Johnson TS, Karakhanova S, Naher H, Mahnke K, Enk AH (2009) Extracorporeal photophoresis augments function of CD4+ CD25+ FoxP3+ regulatory T cells by triggering adenosine production. Transplantation 88:411–416PubMedCrossRef

67.

Morrell MR, Despotis GJ, Lublin DM, Patterson GA, Trulock EP, Hachem RR (2009) The efficacy of photopheresis for bronchiolitis obliterans syndrome after lung transplantation. J Heart Lung Transplant 29:424–431PubMedCrossRef

68.

Meloni F, Cascina A, Miserere S, Perotti C, Vitulo P, Fietta AM (2007) Peripheral CD4(+)CD25(+) TREG cell counts and the response to extracorporeal photopheresis in lung transplant recipients. Transplant Proc 39:213–217PubMedCrossRef

69.

Bluestone JA (2005) CTLA-4Ig is finally making it: a personal perspective. Am J Transplant 5:423–424PubMedCrossRef

70.

Lohr J, Knoechel B, Abbas AK (2006) Regulatory T cells in the periphery. Immunol Rev 212:149–162PubMedCrossRef

71.

Tang Q, Henriksen KJ, Boden EK et al (2003) Cutting edge: CD28 controls peripheral homeostasis of CD4+ CD25+ regulatory T cells. J Immunol 171:3348–3352PubMed

72.

Okazaki M, Sugimoto S, Lai J et al (2009) Costimulatory blockade-mediated lung allograft acceptance is abrogated by overexpression of Bcl-2 in the recipient. Transplant Proc 41:385–387PubMedCrossRef

73.

Bluestone JA, Liu W, Yabu JM et al (2008) The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation. Am J Transplant 8:2086–2096PubMedCrossRef

74.

Vincenti F, Charpentier B, Vanrenterghem Y et al (2010) A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study). Am J Transplant 10:535–546PubMedCrossRef

75.

Dao Nguyen X, Robinson DS (2004) Fluticasone propionate increases CD4CD25 T regulatory cell suppression of allergen-stimulated CD4CD25 T cells by an IL-10-dependent mechanism. J Allergy Clin Immunol 114:296–301PubMedCrossRef

76.

Karagiannidis C, Akdis M, Holopainen P et al (2004) Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol 114:1425–1433PubMedCrossRef

77.

Peek EJ, Richards DF, Faith A et al (2005) Interleukin-10-secreting "regulatory" T cells induced by glucocorticoids and beta2-agonists. Am J Respir Cell Mol Biol 33:105–111PubMedCrossRef

78.

Xystrakis E, Kusumakar S, Boswell S et al (2006) Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J Clin Invest 116:146–155PubMedCrossRef

79.

Yeh SH, Chuang H, Lin LW et al (2009) Regular Tai Chi Chuan exercise improves T cell helper function of patients with type 2 diabetes mellitus with an increase in T-bet transcription factor and IL-12 production. Br J Sports Med 43:845–850PubMedCrossRef

80.

Lowder T, Dugger K, Deshane J, Estell K, Schwiebert LM (2010) Repeated bouts of aerobic exercise enhance regulatory T cell responses in a murine asthma model. Brain Behav Immun 24:153–159PubMedCrossRef

81.

Bergeron A, Belle A, Chevret S et al (2007) Combined inhaled steroids and bronchodilatators in obstructive airway disease after allogeneic stem cell transplantation. Bone Marrow Transplant 39:547–553PubMedCrossRef

82.

De Soyza A, Fisher AJ, Small T, Corris PA (2001) Inhaled corticosteroids and the treatment of lymphocytic bronchiolitis following lung transplantation. Am J Respir Crit Care Med 164:1209–1212PubMed

Titel: Regulatory T cells in lung transplantation—an emerging concept
verfasst von: David C. Neujahr
Christian P. Larsen
Publikationsdatum: 01.03.2011
Verlag: Springer-Verlag
Erschienen in: Seminars in Immunopathology / Ausgabe 2/2011
Print ISSN: 1863-2297
Elektronische ISSN: 1863-2300
DOI: https://doi.org/10.1007/s00281-011-0253-0

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2011

Assessment of kidney organ quality and prediction of outcome at time of transplantation

Lung transplantation: infection, inflammation, and the microbiome

Transplantation and tolerance

Advances of genomic science and systems biology in renal transplantation: a review

Special issues in the management and selection of the donor for lung transplantation